3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals

NCT01721265 · clinicaltrials.gov ↗
TERMINATED
Status
145
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Merck Sharp & Dohme LLC